Department of Basic Medical Sciences, Faculty of Medicine, Galala University, Galala City, 43511, Suez, Egypt.
Department of Medical Biochemistry & Molecular Biology, Faculty of Medicine, Ain Shams University, Cairo, 11566, Egypt.
Sci Rep. 2024 Apr 17;14(1):8820. doi: 10.1038/s41598-024-58840-y.
Zinc ferrite nanoparticles (ZnF NPs) were synthesized by a green method using Psidium guava Leaves extract and characterized via structural and optical properties. The surface of ZnF NPs was stabilized with citric acid (CA) by a direct addition method to obtain (ZnF-CA NPs), and then lipase (LP) enzyme was immobilized on ZnF-CA NPs to obtain a modified ZnF-CA-LP nanocomposite (NCs). The prepared sample's photocatalytic activity against Methylene blue dye (MB) was determined. The antioxidant activity of ZnF-CA-LP NCs was measured using 1,1-diphenyl-2-picryl hydrazyl (DPPH) as a source of free radicals. In addition, the antibacterial and antibiofilm capabilities of these substances were investigated by testing them against gram-positive Staphylococcus aureus (S. aureus ATCC 25923) and gram-negative Escherichia coli (E. coli ATCC 25922) bacterial strains. The synthesized ZnF NPs were discovered to be situated at the core of the material, as determined by XRD, HRTEM, and SEM investigations, while the CA and lipase enzymes were coated in this core. The ZnF-CA-LP NCs crystallite size was around 35.0 nm at the (311) plane. Results obtained suggested that 0.01 g of ZnF-CA-LP NCs achieved 96.0% removal of 5.0 ppm of MB at pH 9.0. In-vitro zone of inhibition (ZOI) and minimum inhibitory concentration (MIC) results verified that ZnF-CA-LP NCs exhibited its encouraged antimicrobial activity against S. aureus and E. coli (20.0 ± 0.512, and 27.0 ± 0.651 mm ZOI, respectively) & (1.25, and 0.625 μg/ml MIC, respectively). ZnF-CA-LP NPs showed antibiofilm percentage against S. aureus (88.4%) and E. coli (96.6%). Hence, ZnF-CA-LP NCs are promising for potential applications in environmental and biomedical uses.
锌铁氧体纳米粒子(ZnF NPs)采用绿色方法,使用番石榴叶提取物合成,并通过结构和光学性质进行了表征。通过直接添加法用柠檬酸(CA)稳定 ZnF NPs 的表面,以获得(ZnF-CA NPs),然后将脂肪酶(LP)固定在 ZnF-CA NPs 上以获得改性 ZnF-CA-LP 纳米复合材料(NCs)。测定了制备样品对亚甲蓝染料(MB)的光催化活性。使用 1,1-二苯基-2-苦基肼(DPPH)作为自由基源来测量 ZnF-CA-LP NCs 的抗氧化活性。此外,通过测试其对革兰氏阳性金黄色葡萄球菌(S. aureus ATCC 25923)和革兰氏阴性大肠杆菌(E. coli ATCC 25922)的抗菌和抗生物膜能力来研究这些物质的抗菌和抗生物膜能力。通过 XRD、HRTEM 和 SEM 研究发现,合成的 ZnF NPs 位于材料的核心位置,而 CA 和脂肪酶酶则涂覆在该核心位置。ZnF-CA-LP NCs 的晶粒度约为 35.0nm 在(311)平面上。结果表明,在 pH 9.0 时,0.01 g 的 ZnF-CA-LP NCs 可去除 5.0 ppm 的 MB 达到 96.0%。体外抑菌圈(ZOI)和最小抑菌浓度(MIC)结果验证了 ZnF-CA-LP NCs 对金黄色葡萄球菌和大肠杆菌表现出令人鼓舞的抗菌活性(分别为 20.0±0.512 和 27.0±0.651 mm ZOI)和(分别为 1.25 和 0.625μg/ml MIC)。ZnF-CA-LP NPs 对金黄色葡萄球菌(88.4%)和大肠杆菌(96.6%)表现出抗生物膜百分比。因此,ZnF-CA-LP NCs 在环境和生物医学应用方面具有广阔的应用前景。